Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016

Details for Mechanism ID: 17114
Country/Region: Burma
Year: 2016
Main Partner: Population Services International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $2,000,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $100,000
Strategic Information (HVSI) $100,000
Testing: HIV Testing and Counseling (HVCT) $600,000
Sexual Prevention: Other Sexual Prevention (HVOP) $350,000
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $250,000
Treatment: Adult Treatment (HTXS) $600,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 231
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 6
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 426
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 11
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 3,490
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 4,589
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 6,477
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 5,893
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 10,624
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 10,499
HTS_TST Service Delivery Point (Facility): Other PITC 2017 7,516
HTS_TST Service Delivery Point (Facility): Other PITC 2017 190
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 3,108
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 84
HTS_TST Sum of Aggregated Age/Sex <15 2017 657
HTS_TST Sum of Aggregated Age/Sex <15 2017 17
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 9,967
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 10,482
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 10,624
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 10,499
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 38
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 1
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 40
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 1
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 363
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 552
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 648
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 706
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 7,500
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 9,544
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 17,044
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 37
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 111
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 103
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 37
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 80
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 40
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 40
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 1
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 40
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1
TB_SCREENDX Screen Result: Screened Positive for TB 2017 1
TB_SCREENDX Screen Results: Screened Positive for TB 2017 40
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 38
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 40
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 463
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 12
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 850
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 22
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 1
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 1
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 1,391
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 2,031
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 74
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 2
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,036
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 28
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 111
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,887
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 51
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 3,108
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 183
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 3,885
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 227
TX_CURR Aggregated Age/Sex: <15 Female 2017 38
TX_CURR Aggregated Age/Sex: <15 Female 2017 1
TX_CURR Aggregated Age/Sex: <15 Male 2017 41
TX_CURR Aggregated Age/Sex: <15 Male 2017 1
TX_CURR Aggregated Age/Sex: 15+ Female 2017 463
TX_CURR Aggregated Age/Sex: 15+ Female 2017 862
TX_CURR Aggregated Age/Sex: 15+ Male 2017 850
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,105
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 1,391
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 1,969
TX_CURR Sum of Aggregated Age/Sex <15 2017 79
TX_CURR Sum of Aggregated Age/Sex <15 2017 2
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 1,313
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 1,967
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 1,392
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 1,969
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 37
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 1
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 52
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 1
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 283
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 441
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 513
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 567
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 886
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,010
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 885
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,010
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 1
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 35
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 146
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 324
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 9
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 505
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 959
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 578
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,067
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 35
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 182
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 361
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 10